France

On July 29, 2025, the French National Authority for Health (HAS) issued positive opinions on including targeted next-generation sequencing-based panels in certain clinical indications for patients with aminoacidopathy and acute leukaemia in the NABM Nomenclature for regular reimbursement. Currently, these tests are temporarily reimbursed within the innovative payment scheme (RIHN). These HAS assessments are performed by HAS as a part of the RIHN reform and ‘cleaning up’ the List of temporary covered tests.

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the July 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Four favourable opinions were issued concerning add-on reimbursement for medical devices in the orthopedics and ENT fields.

On July 15, 2025, the Ministry of Labor, Health, Solidarity, and Families published the instruction on the application for coverage with evidence development programs for 2025-2026. The instruction details the specific fields of research, the application procedures, and the deadlines for different types of programs (PHRC, PRME, PREPS, PHRIP, and PRT).

On July 10, 2025, a decision of the National Union of Health Insurance Funds regarding the update of the CCAM Classification of Medical Procedures was published. The update includes the provisional registration of one procedure code for transrectal HIFU destruction of prostate lesions and changes to indications and billing notes for several existing codes. The update takes effect on September 1, 2025.

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the June 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Seven favourable opinions were issued concerning add-on reimbursement for medical devices in the cardiovascular, peripheral vascular, and ophthalmology fields.

On June 18, 2025, a new version of the Nomenclature of Medical Biology Procedures (NABM 98) was released. Seven new codes were introduced.

On June 5, 2025, the French National Authority for Health (HAS) published its favorable opinion on the coverage of AI-assisted digitalized urine cytology using VisioCyt Bladder, an in-vitro diagnostic medical device, under the renewed Repository of Innovative Procedures outside the Nomenclature of Biology and Anatomocytopathology (RIHN) 2.0.

On May 27, 2025, a new version of the Nomenclature of Medical Biology Procedures (NABM 97) was released. Changes concerned the introduction of a new code and modifications to the descriptions and wording of several existing codes.

The French National Authority for Health (HAS) released new recommendations regarding the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the May 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). One favourable opinion was issued concerning add-on reimbursement for medical device in the men’s health field.

In April 2025, the French National Authority for Health (HAS) opened the application period for including medical procedures and in-vitro diagnostic tests in its 2026 evaluation working program. The application deadline is July 8, 2025.

The French National Authority for Health (HAS) released new recommendations regarding the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the April 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Eleven favorable opinions were published concerning the registration of new devices or modifying conditions/indications for existing ones in the LPPR List. The recommendations relate to devices in the fields of endocrine, e-health, neuromodulation, peripheral vascular, and medical aids.

On March 19, 2025, the Ministry of Labor, Health, Solidarity and Families published the Decree establishing a regulatory framework for the restoration and traceability of medical devices for individual use. It mandates that only certified centers may perform refurbishment, introduces a national registry for tracking restored devices, and links LPPR reimbursement to compliance with restorability criteria (pending further specification of applicable device categories).